Educational resources about the HPV vaccine and HPV-related cancers. Compiled by The University of Texas MD Anderson Cancer Center Office of Health Policy.
Updated February 2021
Project ECHO® at MD Anderson
Project ECHO® was developed in 2003 by Dr. Sanjeev Arora of the University of New Mexico in response to a high prevalence of untreated Hepatitis C (HCV) in the state. Using this model, Dr. Arora conducted a prospective clinical trial, the results of which were published in 2011 in the New England Journal of Medicine. Dr. Arora conducted weekly videoconferences with primary care providers in 16 community clinics and 5 prisons in New Mexico. Patient cases were presented, and a multidisciplinary team at the UNM provided clinical mentoring, evidence-based advice on patient management and regular didactic education sessions. At the end of the study period, the outcomes of patients treated by specialists at UNM were compared with those of patients treated by primary care providers. The study found no significant differences in sustained viral response between the UNM cohort and the ECHO cohort. The study concluded that the ECHO model is safe and effective in treating HCV in underserved communities.
The Project ECHO model has since expanded to more than 87 hubs worldwide for nearly 30 diseases and conditions. These specialties include infectious diseases, rheumatologic diseases, chronic pain, addiction, HIV diabetes, complex multisystem disease, cancer prevention and hospice care. The VA, DOD and CDC have ongoing ECHO clinics. At MD Anderson projects are currently focused on Cervical Cancer Prevention, Management of Cervical and Breast Cancer, Tobacco Cessation for Mental Health centers, Survivorship, Palliative Care and Pathology. Visit the Project ECHO website at http://www.mdanderson.org/projectECHO to learn more.
These clinical practice algorithms have been specifically developed for MD Anderson using a multidisciplinary approach and taking into consideration circumstances particular to MD Anderson, including the following: MD Anderson’s specific patient population; our services and structure; and our clinical information. Moreover, these algorithms are not intended to replace the independent medical or professional judgment of physicians or other health care providers.
Disclaimer: These algorithms are not intended to replace the independent medical judgment of the physician or other health care providers in the context of individual clinical circumstances to determine a patient's care.
American Academy of Pediatrics HPV Champion Toolkit
The American Academy of Pediatrics has created an HPV toolkit. August is a perfect time to review materials like this and ask yourself if they may be useful in your work.
Link to toolkit: https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/immunizations/HPV-Champion-Toolkit/Pages/HPV-Champion-Toolkit.aspx
This toolkit has resources to help providers:
The National HPV Vaccination Roundtable Clinician & Health Systems Action Guides
The National HPV Vaccination Roundtable believes that every health care professional plays an important role in increasing HPV vaccination rates.
Members of the Provider Training Task Group developed a suite of 6 Clinician & System Action Guides to encourage providers, support teams, and health systems to take action today.
Released in February 2018.
HPV, Cancer and Dental Providers,August 18, 2020 at 6:30 PM ET
REGISTER USING THIS LINK: https://zoom.us/webinar/register/WN_vmBE5pzeQ2Oxf_JDPr_xKQ
If you are interested, but cannot attend on the 18th, please contact Kelly Welch at Kelly@TeamMaureen.org
The FREE presentation is intended for DENTISTS, HYGIENISTS, DENTAL ASSISTANTS and DENTAL STUDENTS. Continuing Education Credit available. (1 hour) National expert, Dr. Alessandro Villa, DDS, PhD, MPH, will discuss:
Are you a nurse interested in empowering your clinical team to confidently initiate and complete the HPV vaccine series for your patients? The National HPV Vaccination Roundtable is hosting a train-the-trainer webinar on the HPV Prevention: Nurses Get it Done! toolkit on March 11th at 3:30pm ET. This one-hour webinar will train nurses to use the Nurses Get it Done toolkit to teach the following:
The Us vs. HPV online webinar series, hosted by the American Medical Women's Association (AMWA), Global Initiative Against HPV and Cervical Cancer (GIAHC), and Indiana University, National Center of Excellence in Women's Health took place from January 27-31 2020. We had a very successful week, with the World Health Organization elaborating on the cervical cancer elimination initiative and many expert speakers discussing the 6 different types of cancers that HPV causes and the effective and excellent tools that we currently have to prevent majority of these cancers. The webinars are intended for members of the public, patients, healthcare providers, and anyone else who wishes to learn more about various aspects of HPV-related diseases and HPV prevention.
Visit the Us vs. HPV Archive to see videos from the 2020 and 2019 webinars: https://www.giahc.org/us-vs-hpv-archive.html.
View/dounlad a PDF of the National HPV Vaccination Roundtable slides from their presentation WE’RE IN! 2020 HPV Cancer Prevention Initiative for Health Systems: http://hpvroundtable.org/wp-content/uploads/2020/01/Were-In-2020-LAUNCH-WEBINAR-Slides_FINAL.pdf,
The human papillomavirus (HPV) vaccine could prevent up to 90 percent of cervical cancer cases plus a range of other cancers, including many for which there is no routine screening. Texas pediatricians play a significant role in educating patients and their parents about why it is important to be vaccinated as recommended. This podcast, by Dr. John Hellerstedt, Commissioner, Texas Department of State Health Services, provides an overview of current research and offers practical guidance about how to promote routine HPV vaccination in your practice.
Dr. Hellerstedt has served as DSHS commissioner since January 2016 and is a leading spokesman for public health issues in the state. Dr. Hellerstedt is a long-time Texas pediatrician who has been chief medical officer at the Seton Family of Hospitals and vice president of medical affairs at Dell Children’s Medical Center, both in Austin. He previously served the state as medical director for Medicaid and the Children’s Health Insurance Program.
The University of Texas MD Anderson Cancer Center - Institutional Strategic Framework to Increase HPV Vaccination (PDF) New!
In 2020, The University of Texas MD Anderson Cancer Center adopted an Institutional strategic framework to increase HPV V=accination (Framework). The Framework outlines selected areas for action for MD Anderson and these areas are visually represented in a logic model. Creating a framework allows the institution to develop a common set of definitions while establishing an operations and implementation structure. It also reinforces accountability. The Framework is organized in a manner that aligns with common elements from CDC’s Strategic Framework for Global Immunization, 2016-2020, HPV Vaccination for Cancer Prevention: Progress, Opportunities, and a Renewed Call to Action: A Report to the President of the United States from the Chair of the President’s Cancer Panel (2018 Nov), and World Health Organization’s Global Routine Immunization Strategies and Practices (GRISP): a companion document to the Global Vaccine Action Plan (GVAP).
HPV Vaccine Uptake in Texas Pediatric Care Settings: 2014-2015 Environmental Scan Report
CDC - Adolescent #HowIRecommend Vaccination Video Series New
Just like you, each clinician featured in the #HowIRecommend video series is unique in their conversational style and approach to answering parents’ questions or concerns about HPV vaccine, with a common goal to protect their patients from cancers caused by HPV. Learn how they answer common questions you get every day. The #HowIRecommend video series is organized two ways:
Houston Health Department Video (parent video) - It’s worth a shot: HPV vaccination is cancer prevention
If there were a vaccine against cancer, would you get it for your kids? HPV is a very common virus, infecting about 14 million people annually. This educational video addresses this importance of adolescents receiving protection against HPV, a cancer-causing disease, and provides an overview of HPV vaccine recommendations. Physicians Julie Boom, MD, Lois Ramondetta, MD, Erich Sturgis, MD, and David Persse, MD, share their expertise, discuss HPV vaccine safety and talk about the importance of HPV vaccination.
Houston Health Department Video (provider video) - It’s worth a shot: HPV vaccine recommendations matter
Did you know the healthcare provider recommendation is the single best predictor of vaccination? What you say, and how you say it, matters. This informative video highlights physicians, Julie Boom, MD, Lois Ramondetta, MD, Erich Sturgis, MD, and David Persse, MD sharing their expertise on HPV and HPV vaccination, including how to strongly recommend the vaccine to patients/parents of your patients.
MD Anderson Cancer Center Video - Help kids prevent cancer
The HPV vaccine is the best protection against the HPV virus and the cancers it causes. All boys and girls between 11 and 12 should get the HPV vaccine. The vaccine is given at this age for maximum immunity. About 80% of people – both men and women – will get a human papillomavirus (HPV) infection at some point in their lives. The HPV vaccine is a safe and effective vaccination against cancer.
MD Anderson Cancer Center Video - Squamous cell carcinoma survivor on the importance of the HPV vaccine
Rob Joyce, 61, was diagnosed with squamous cell carcinoma on the base of his tongue. The biopsy done by his Ear, Nose and Throat physician revealed that his cancer was caused by the human papillomavirus (HPV). Listen to Rob tell his story and explain why the HPV vaccine is so important to today's youth.
MD Anderson Cancer Center Video - Cervical cancer patient wishes the HPV vaccine had been available to her
Constance Hill was diagnosed with cervical cancer, caused by the human papillomavirus (HPV), in May 2014. She underwent a radical hysterectomy, radiation and chemotherapy, and brachytherapy. Then she had a recurrence and was placed on a Phase II clinical trial using the HPV vaccine and immunotherapy. Her cervical cancer is still present, so she is beginning a style="color:black;text-decoration:none;font-weight:bold;" targeted therapy Phase I clinical trial. In her mind, all of this could have been avoided if the HPV vaccine was available to her as a child. Hear Constance tell her story.
MD Anderson Cancer Center Video - Patient fights the stigma of HPV-related cancers
At age 62, Tom Jackson was diagnosed with prostate cancer. The diagnosis is common among men his age, so he took it in stride. But shortly before Tom was scheduled to have his prostate removed, he discovered a lump on his neck. A biopsy and CT scan of the lump revealed that Tom also had squamous cell carcinoma of the tonsil caused by the human papillomavirus (HPV).
MD Anderson Cancer Center Video - Caregiver and cancer patient shares her HPV journey
Suzanne Armstrong was diagnosed with squamous cell carcinoma of the tonsil in December 2016. She noticed a lump on her neck, which once biopsied, turned out to be HPV-related. Listen to Suzanne tell her story and the difficulty she faced when having to undergo treatment at age 70, only six-months after her husband passed away from cancer.
MD Anderson Cancer Center Video - Squamous cell carcinoma survivor's thoughts on the HPV vaccine
Scott Courville was diagnosed with squamous cell carcinoma of the right tonsil in 2016. What two separate doctors thought was tonsillitis, turned out to be cancer caused by the human papillomavirus (HPV). Following numerous rounds of chemotherapy and radiation treatment, Scott now encourages all parents, like himself, to make sure their children get vaccinated. Hear Scott's advice for parents.
Rice University’s Baker Institute for Public Policy, Panel Discussion, December 2, 2016 - HPV-Related Cancers: Opportunities for Cancer Prevention
In the United States, 79 million men and women — approximately one in four — are currently infected with the human papillomavirus (HPV). From 2008 to 2012, nearly 40,000 HPV-related cancers occurred annually in the United States. Today, highly effective HPV vaccines could easily reduce these numbers, but only 42 percent of girls and 28 percent of boys aged 13 to 17 have received the vaccine — far below the 80 percent of American adolescents the Centers for Disease Control and Prevention (CDC) aim to reach. At this event, leaders from the CDC, Texas state government and The University of Texas MD Anderson Cancer Center discussed HPV, HPV-associated cancers, life-saving cancer prevention opportunities through HPV vaccination, barriers to HPV vaccination programs and a proposed plan to promote HPV vaccination in Texas.
This panel discussion was the eighth event in the Medicine, Research and Society Policy Issues Series, a joint project of the Baker Institute Center for Health and Biosciences and The University of Texas MD Anderson Cancer Center.
Confronting Cancer: MD Anderson supports the HPV vaccine
MD Anderson supports the HPV vaccine for the prevention of several types of cancer. Learn more at MakingCancerHistory.com/HPV.
MD Anderson Cancer Center Video - Why my kids get the HPV vaccine: A cervical cancer survivor’s story
As a cervical cancer survivor and parent to two sons, Linda Ryan advises other parents to vaccinate their kids against the human papillomavirus (HPV). She wishes the HPV vaccine had been available to her as an adolescent so she could have avoided cervical cancer, which is predominantly caused by HPV.
MD Anderson Cancer Center Video - Cancer survivor Kara Million on the importance of HPV vaccinations
Cancer survivor Kara Million was diagnosed with cervical cancer, which was caused by the human papillomavirus (HPV) infection. She is now an advocate for the HPV vaccine. Watch as she shares her story and urges everyone to protect their children with the HPV vaccine.